Dinoprostone (Compound)

Synonyms:Prostaglandin E2, Dinoprostone, PGE2, 363-24-6, Prostin E2, Prepidil, Minprostin E2, Cervidil, Propess, Minprositin E2, Dinoproston, Prostin, (15S)-Prostaglandin E2, Prostarmon E, Dinoprostonum, l-Prostaglandin E2, Dinoprostona, Glandin, Enzaprost E, l-PGE2, (5Z,11alpha,13E,15S)-11,15-dihydroxy-9-oxoprosta-5,13-dien-1-oic acid, U-12062, Prostaglandin E, (E,Z)-(1R,2R,3R)-7-(3-Hydroxy-2-((3S)-(3-hydroxy-1-octenyl))-5-oxocyclopentyl)-5-heptenoic acid, NSC 165560, [3H]PGE2, U 12062, [3H]prostaglandin E2, (-)-Prostaglandin E2, (Z)-7-((1R,2R,3R)-3-Hydroxy-2-((S,E)-3-hydroxyoct-1-en-1-yl)-5-oxocyclopentyl)hept-5-enoic acid, (Z)-7-[(1R,2R,3R)-3-Hydroxy-2-[(E,3S)-3-hydroxyoct-1-enyl]-5-oxocyclopentyl]hept-5-enoic acid, Prostaglandin E2 (GMP), CHEMBL548, NSC 196514, NSC-165560, NSC-196514, K7Q1JQR04M, 7-(3-Hydroxy-2-(3-hydroxy-1-octenyl)-5-oxocyclopentyl)-5-heptenoic acid, l-7-(3-Hydroxy-2-(3-hydroxy-1-octenyl)-5-oxocyclopentyl)-5-heptenoic acid, DTXSID4022947, (5Z,13E)-(15S)-11alpha,15-Dihydroxy-9-oxoprost-13-enoate, CHEBI:15551, (5Z,13E)-(15S)-11alpha,15-dihydroxy-9-oxoprosta-5,13-dienoate, U-12,062, 5-Heptenoic acid, 7-(3-hydroxy-2-(3-hydroxy-1-octenyl)-5-oxocyclopentyl)-, 5-Heptenoic acid, 7-(3-hydroxy-2-(3-hydroxy-1-octenyl)-5-oxocyclopentyl)-, l-, PGE2alpha, Prosta-5,13-dien-1-oic acid, 11,15-dihydroxy-9-oxo-, (5Z,11alpha,13E,15S)-, Prostaglandin E(2), (Z)-7-[(1r,2r,3r)-3-Hydroxy-2-[(E,3s)-3-Hydroxyoct-1-Enyl]-5-Oxo-Cyclopentyl]hept-5-Enoic Acid, NCGC00092361-05, Prostaglandin E2alpha, Prostaglandin E2.alpha., (5Z,13E,15S)-11alpha,15-dihydroxy-9-oxoprosta-5,13-dien-1-oic acid, Dinoprostonum [INN-Latin], 9-oxo-11R,15S-dihydroxy-5Z,13E-prostadienoic acid, Dinoprostona [INN-Spanish], DTXCID002947, Cerviprime, Prostenone, 7-[3-Hydroxy-2-(3-hydroxy-1-octenyl)-5-oxocyclopentyl]-5-heptenoic acid, Prostarmon E2, Prosta-5,13-dien-1-oic acid, 11,15-dihydroxy-9-oxo-, (5Z,11.alpha.,13E,15S)-, Cervidil (TN), Prepidil (TN), (5Z)-7-[(1R,2R,3R)-3-hydroxy-2-[(1E,3S)-3-hydroxyoct-1-en-1-yl]-5-oxocyclopentyl]hept-5-enoic acid, CAS-363-24-6, Dinoprostone Prostaglandin E2, U,062, Prostin E2 (TN), PGE2-[3,3,4,4-d4], SR-05000001459, EINECS 206-656-6, UNII-K7Q1JQR04M, Dinoprostone (JAN/USP/INN), (5Z,13E,15S)-11,15-Dihydroxy-9-oxoprosta-5,13-dien-1-oic acid, BML1-F07, Prosta-5, (5Z,11.alpha.,13E,15S)-11,15-dihydroxy-9-oxo-, Prosta-5, 11,15-dihydroxy-9-oxo-, (5Z,11.alpha.,13E,15S)-, Prosta-5, 11,5-dihydroxy-9-oxo-, (5Z,11.alpha.,13E,15S)-, [3H]dinoprostone, 5-Heptenoic acid, 7-[3-hydroxy-2-(3-hydroxy-1-octenyl)-5-oxocyclopentyl]-, prosta-glandin e2, NCGC00092361-06, (E,2R,3R)-7-[3-hydroxy-2-[(3S)-(3-hydroxy-1-octenyl)]-5-oxocyclopentyl]-5-heptenoic acid, (E,Z)-(1R,2R,3R)-7-[3-hydroxy-2-[(3S)-(3-hydroxy-1-octenyl)]-5-oxocyclopentyl]-5-heptenoic acid, P2E, Prestwick_793, (5Z,11-alpha,13E,15S)-11,15-Dihydroxy-9-oxoprosta-5,13-dien-1-oic acid, MFCD00077861, [3H]prostin E2, BMS-279654 & PGE2, Dinoprostone beta-Cyclodextrin Clathrate, Dinoprostone [USAN:USP:INN:BAN:JAN], (5Z,11alpha,13E,15S)-11,15-Dihydroxy-9-oxoprosta-5,13-dien-1-oic, DINOPROSTONE [INN], DINOPROSTONE [JAN], DINOPROSTONE [USAN], (+/-)-Prostaglandin E2, Prostaglandin E2 (PGE2), DINOPROSTONE [VANDF], SCHEMBL25533, BSPBio_001490, DINOPROSTONE [MART.], DINOPROSTONE [USP-RS], DINOPROSTONE [WHO-DD], PROSTAGLANDIN E2 [MI], GTPL1883, GTPL1916, [3H]-PGE2, BDBM35847, DTXSID00859353, DINOPROSTONE [ORANGE BOOK], HMS1361K12, HMS1791K12, HMS1989K12, HMS2089D17, HMS3268J12, HMS3402K12, HMS3413C20, HMS3648F07, HMS3677C20, DINOPROSTONE [EP MONOGRAPH], DINOPROSTONE [USP IMPURITY], (Z)-7-((1R,2R,3R)-3-hydroxy-2-((S,E)-3-hydroxyoct-1-enyl)-5-oxocyclopentyl)hept-5-enoic acid, AMY30102, EX-A1773, DINOPROSTONE [USP MONOGRAPH], Tox21_111196, HB3460, LMFA03010003, NSC165560, NSC196514, s3003, (5Z,11.alpha.,13E,15S)-11,15-Dihydroxy-9-oxoprosta-5,13-dien-1-oic acid, AKOS015920228, Tox21_111196_1, AC-6098, CCG-208092, CCG-208256, CS-6932, DB00917, HY-101952G, IDI1_033960, Prosta-5,13-dien-1-oic acid, (5Z,11-alpha,13E,15S)-11,15-dihydroxy-9-oxo-, SMP2_000056, NCGC00092361-01, NCGC00092361-02, NCGC00092361-03, NCGC00092361-04, AS-71847, Dinoprostone 100 microg/mL in Acetonitrile, HY-101952, ALPROSTADIL IMPURITY G [EP IMPURITY], CS-0626105, P1884, C00584, D00079, Prostaglandin E2, >=93% (HPLC), synthetic, A823207, EN300-22411484, Q416554, SR-01000946417, J-502620, SR-01000946417-1, SR-05000001459-1, SR-05000001459-3, SR-05000001459-4, BRD-K26521938-001-04-9, 05D31BD5-818B-4A92-8CFC-BEC19926A5B3, 2-AMINO-1-BENZO[1,3]DIOXOL-5-YL-ETHANONEHYDROCHLORIDE, Dinoprostone, European Pharmacopoeia (EP) Reference Standard, (5Z,13E)-(15S)-11alpha,15-Dihydroxy-9-oxoprost-13-enoic acid, (5Z,13E,15S)-11-alpha,15-dihydroxy-9-oxoprost-5,13-dienoate, Dinoprostone, United States Pharmacopeia (USP) Reference Standard, (5Z,11?,13E,15S)-11,15-Dihydroxy-9-oxo-prosta-5,13-dien-1oic acid, (5Z,11I+/-,13E,15S)-11,15-Dihydroxy-9-oxoprosta-5,13-dienoic acid, (5Z,13E)-(15S)-11alpha,15-Dihydroxy-9-oxoprosta-5,13-dienoic acid, (5Z,13E,15S)-11-alpha,15-dihydroxy-9-oxoprost-5,13-dienoic acid, 5Z,11alpha,13E,15S)-11,15-Dihydroxy-9-oxo-rosta-5,13-dien-1-oic acid, Prostaglandin E2, synthetic, powder, BioReagent, suitable for cell culture, (5Z,11alpha,13E,15S)-11,15-Dihydroxy-9-o xo-prosta-5,13-dien-1oic acid, Prostaglandin E2, gamma-irradiated, powder, BioXtra, suitable for cell culture, 22230-04-2

Id:5280360

Description:nan